Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ICU MEDICAL INC/DEICUI · Entity 2385 | VP, General Counsel | September 03, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ICU MEDICAL INC/DE
Report date September 03, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,604 |
Ending reported balance
After 2026-09-03 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-09-03 · Sale · Disposed 2,202 · Balance 17,258 F1: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.20 to $168.145, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Row 2 · 2026-09-03 · Sale · Disposed 1,238 · Balance 16,020 F1: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.21 to $169.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Row 3 · 2026-09-03 · Sale · Disposed 724 · Balance 15,296 F1: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.5 to $169.665, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Row 4 · 2026-09-03 · Sale · Disposed 692 · Balance 14,604 F1: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.775 to $171.69, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.20 to $168.145, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.21 to $169.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.5 to $169.665, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.775 to $171.69, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 27, 2019 Filed Mar 28, 2019 17:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 295 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-19-000009 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,462 Read SEC document |
| March 07, 2019 Filed Mar 8, 2019 18:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 200 | $233.35 | $46,670.00 |
DisclosureSEC source: 0001669639-19-000007 · edgardoc.xml · nonDerivative · entry 5 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,757 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018. F4 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $233.31 to $233.38, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 07, 2019 Filed Mar 8, 2019 18:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,980 | $232.67 | $693,356.60 |
DisclosureSEC source: 0001669639-19-000007 · edgardoc.xml · nonDerivative · entry 4 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,957 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018. F3 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $232.28 to $233.27, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 07, 2019 Filed Mar 8, 2019 18:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,097 | $231.70 | $485,874.90 |
DisclosureSEC source: 0001669639-19-000007 · edgardoc.xml · nonDerivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,937 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018. F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $231.22 to $232.11, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 18:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 3,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-19-000007 · edgardoc.xml · derivative · entry 6 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,410 shares Expires 2019-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F7 · shares: Each PRSU reflects the contingent right to receive a variable number of shares of common stock based on achieving performance goals. At the determination date, based on certification of the achievement of the performance criteria, the reporting person earned 300% of the target award amount. F8 · derivative.exercise_date: These PRSUs were granted on February 5, 2016. The vesting for these PRSUs is dependent upon the achievement of performance criteria related to the Company's fiscal year 2018 Adjusted EBITDA per share CAGR in comparison to the fiscal year 2015 Adjusted EBITDA per weighted average basic share. The reporting person may potentially earn 100% to 300% of the target award amount originally reported on the date of grant. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 18:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 5,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-19-000007 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,034 Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 18:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 10,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-19-000007 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2019 Filed Feb 22, 2019 17:20 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 1,006 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-19-000005 · edgardoc.xml · derivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,011 Underlying: Common Stock · 1,006 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the performance stock units. F3 · derivative.exercise_date: These performance stock units were granted on March 6, 2018. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These performance stock units vest on February 15 of the first, second, and third year following the year of grant. Read SEC document |
| February 15, 2019 Filed Feb 22, 2019 17:20 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 348 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-19-000005 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,757 Read SEC document |
| February 15, 2019 Filed Feb 22, 2019 17:20 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-19-000005 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 02:10 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,157 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-19-000003 · edgardoc.xml · derivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,157 shares Expires 2019-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 02:10 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,157 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-19-000003 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,099 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 02:10 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-19-000003 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 942 Read SEC document |
| August 28, 2018 Filed Aug 29, 2018 22:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 787 | $303.12 | $238,555.44 |
DisclosureSEC source: 0001669639-18-000010 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,367 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| August 24, 2018 Filed Aug 27, 2018 19:07 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 3,049 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-18-000008 · edgardoc.xml · derivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,049 shares Expires 2018-08-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| August 24, 2018 Filed Aug 27, 2018 19:07 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-18-000008 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,154 Read SEC document |
| August 24, 2018 Filed Aug 27, 2018 19:07 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 3,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-18-000008 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| May 15, 2018 Filed May 15, 2018 17:40 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 500 | $269.85 | $134,925.00 |
DisclosureSEC source: 0001669639-18-000006 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 617 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| March 27, 2018 Filed Mar 28, 2018 22:45 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 592 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-18-000004 · edgardoc.xml · derivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,186 Underlying: Common Stock · 592 shares Expires 2020-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 27, 2018 Filed Mar 28, 2018 22:45 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 205 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-18-000004 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,117 Read SEC document |
| March 27, 2018 Filed Mar 28, 2018 22:45 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 592 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-18-000004 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 17:38 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,157 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-18-000002 · edgardoc.xml · derivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,157 Underlying: Common Stock · 1,157 shares Expires 2019-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 17:38 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 427 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-18-000002 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 730 Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 17:38 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,157 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-18-000002 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| September 07, 2017 Filed Sep 7, 2017 21:19 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 102 | $174.54 | $17,802.70 |
DisclosureSEC source: 0001669639-17-000006 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| September 07, 2017 Filed Sep 7, 2017 21:19 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 1,682 | $174.46 | $293,444.92 |
DisclosureSEC source: 0001669639-17-000006 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| August 24, 2017 Filed Aug 24, 2017 22:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 3,049 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-17-000005 · edgardoc.xml · derivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,049 Underlying: Common Stock · 3,049 shares Expires 2018-08-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| August 24, 2017 Filed Aug 24, 2017 22:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,265 | $167.95 | $212,456.75 |
DisclosureSEC source: 0001669639-17-000005 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,784 Read SEC document |
| August 24, 2017 Filed Aug 24, 2017 22:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 3,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-17-000005 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2017 Filed Apr 4, 2017 01:37 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 1,778 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-17-000004 · edgardoc.xml · derivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,778 Underlying: Common Stock · 1,778 shares Expires 2020-03-27 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017. F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F5 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 27, 2017 Filed Apr 4, 2017 01:37 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 1,778 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-17-000004 · edgardoc.xml · derivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,778 Underlying: Common Stock · 1,778 shares Expires 2019-12-31 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017. F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: The vesting for this performance-based restricted stock unit ("PRSU") award is dependent upon the reporting person's earning PRSUs based on the achievement of performance criteria related to the Company's fiscal year 2019 Cumulative Adjusted EBITDA in comparison to the fiscal year 2016 Adjusted EBITDA. The number of shares reported is the target award amount. The reporting person may potentially earn PRSUs ranging from 100% to 300% of the target award amount. Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 01:05 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 681 | $148.38 | $101,044.06 |
DisclosureSEC source: 0001669639-17-000002 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: These securities are Restricted Stock Units. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| February 05, 2017 Filed Feb 6, 2017 17:31 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,156 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-17-000001 · edgardoc.xml · derivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,314 Underlying: Common Stock · 1,156 shares Expires 2019-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units and were granted on 2/5/2016. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| February 05, 2017 Filed Feb 6, 2017 17:31 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 475 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-17-000001 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 681 Read SEC document |
| February 05, 2017 Filed Feb 6, 2017 17:31 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-17-000001 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units and were granted on 2/5/2016. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 20:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 1,903 | $121.29 | $230,824.19 |
DisclosureSEC source: 0001669639-16-000003 · edgardoc.xml · nonDerivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: These securities are Restricted Stock Units. F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F3 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $121.11 to $121.31, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| August 24, 2016 Filed Sep 13, 2016 20:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 3,049 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-16-000003 · edgardoc.xml · derivative · entry 4 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,098 Underlying: Common Stock · 3,049 shares Expires 2018-08-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F4 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F5 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| August 24, 2016 Filed Sep 13, 2016 20:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-16-000003 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,903 Read SEC document |
| August 24, 2016 Filed Sep 13, 2016 20:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 3,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-16-000003 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.